Laura J. Esserman

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Biological subphenotypes in severe acute hypoxaemic respiratory failure and acute respiratory distress syndrome using rapid prospective classification (SPARC) in the USA: a multicentre, observational, study

  The Lancet Respiratory Medicine · 2026-05-01

• Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer

  Science Translational Medicine · 2026-04-22

• WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and DesignPreprint

  Research Square · 2025-12-15

• Germline Pathogenic Variants Among Women Without a History of Breast Cancer

  JAMA Internal Medicine · 2025-12-12 · 2 citations

• Risk-Based vs Annual Breast Cancer Screening

  JAMA · 2025-12-12 · 34 citations

• Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

  Nature Communications · 2025-12-09 · 6 citations

• Multicenter Interspecialty Consensus on Experimental Oncology Drug–Related Ocular Adverse Event Reporting

  JAMA Ophthalmology · 2025-12-04 · 5 citations

• Supplementary Table 1 from Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes

  2025-11-26

• Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial

  Communications Medicine · 2025-10-29

• Progesterone receptor ( <scp>PR</scp> ) intra‐tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial

  International Journal of Cancer · 2025-10-24

• CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial

  npj Breast Cancer · 2025-10-24

• Supplementary Figure 1 from Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti–Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast CancerPreprint

  2025-10-15

• Data from Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti–Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast CancerPreprint

  2025-10-15

• Supplementary Tables 1 from Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti–Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer

  2025-10-15

• FNA biopsy of breast specimens effectively harvests cells for patient‐derived organoids modeling ductal carcinoma in situ

  Cancer Cytopathology · 2025-10-09 · 1 citations

• WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and DesignPreprint

  npj Breast Cancer · 2025-10-05 · 1 citations

• ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial

  Annals of Surgical Oncology · 2025-08-29

• Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial

  Genome Medicine · 2025-08-28 · 12 citations

• Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapiesPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-08-28

• Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast CancerPreprint

  medRxiv · 2025-08-27